TALi Health wins £25K of support for UK expansion

"The attention people"

Pioneering children’s health education gaming venture TALi Health — which tackles the growing challenges of clinical attention deficits symptomatic of ADHD and Autism Spectrum Disorders — has been named as the winner of Newfound’s first Go-No-Go campaign competition — gaining access to more than £25,000 of support to help its expansion into the UK market.

TALi Technology

Melbourne-based TALi, founded in 2016, creates game-based programs to assess and improve attention in young children aged three to eight. Its ground-breaking technology , based on 25 years of clinical research, and commercialised by a team of developers, designers, scientists and entrepreneurs, includes the TALi Detect Digital Attention Assessment tool to flag children that require support and the TALi Train digital training program that has been clinically validated to boost attention in children in just five weeks.

A study by researchers at CDC revealed that 1 in 10 school-age children in the US were diagnosed with ADHD — roughly 11% of the population, with worldwide prevalence ranging from 8–12%. With the global challenge of attention difficulties growing, it is clear that TALi’s technology has real potential for impact at scale.

Newfound Go-No-Go

Newfound’s competition, which ran over the summer, was devised to highlight its new Go-No-Go programme, created to help companies validate their UK market entry plans. Entries to the competition were judged by a UK panel of leading advisers, investors and B2B experts.

A study by researchers at CDC revealed that 1 in 10 school-age children in the US were diagnosed with ADHD — roughly 11% of the population, with worldwide prevalence ranging from 8–12%. With the global challenge of attention difficulties growing, it is clear that TALi’s technology has real potential for impact at scale.

In their entries, ventures needed to show that they have:

achieved commercial success in their local market
a clear product roadmap
a product with global scalability
readiness to expand their business.

All competition winners and runners up demonstrated that they met these criteria — with TALi being the one that judges felt would derive the most value from research to inform their go/no-go decision.

Commenting on the competition, Newfound CEO Peter Gillingwater said:

With more than 30 global B2B SaaS businesses entering into the Go-No-Go competition we were very impressed by the overall quality and potential of most of them. Leaving your home markets on an overseas expansion is full of both risk and opportunity — and we decided to choose TALi because of its amazing mission and the global need for a solution of their type.

Any game-changing business needs a great product and team and we look forward to working with them to build the plan & scale into the UK and Europe with quality speed and execution.

The competition win means that TALI gains access to £25,000 worth of UK market validation support services, including access to professional research and analysis services.

Commenting on the competition win, TALi Health director Glenn Smith said:

TALi is honoured to be selected to take part in the Newfound Go-No-Go programme. Peter and his team at Newfound have decades of experience partnering with tech SMEs wishing to enter the UK.

Newfound’s expertise in assessing market opportunity, identifying government and industry partners, raising brand awareness, recruitment, as well as their proven success Australasian tech SMEs, will greatly assist in fulfilling TALi’s ambition of getting our digital screening and cognitive training platform into the hands of children that will benefit most improve attentional capabilities.

This is an invaluable opportunity to accelerate TALi’s growth in the UK market complementing our existing initiatives with edtech impact.